Please assess the completion status of the following clinical trial:

Trial Title: The Baerveldt Versus ClearPath Comparison Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Men or women with age at screening ≥ 18 years and ≤ 90 years~* Inadequately controlled glaucoma~* Valve-less aqueous shunt as the planned surgical procedure~* Patients with primary glaucomas or pseudoexfoliation, pigmentary and traumatic glaucoma with a previous failed trabeculectomy or other intraocular surgery included.~* Primary tubes included~* Investigators to recruit consecutively all eligible patients from their clinics.~* Superotemporal or inferonasal placement of the tube~* Capable and willing to provide consent~Exclusion Criteria:~* NLP~* Unable/unwilling to provide informed consent~* Unavailable for regular follow up~* Previous cyclodestructive procedure~* Prior scleral buckling procedure or other external impediment to supratemporal drainage device implantation~* Presence of silicone oil~* Vitreous in the anterior chamber sufficient to require a vitrectomy~* Uveitic glaucoma~* Neovascular glaucoma~* Nanophthalmos~* Sturge-Weber syndrome or other conditions associated with elevated episcleral venous pressure~* Procedure combined with other surgery~* Any abnormality other than glaucoma in the study eye that could affect tonometry.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Baerveldt 350 implant (Type: ACTIVE_COMPARATOR): None
- Ahmed ClearPath 350 implant (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).